Drug recall · October 15, 2014
Tarceva recall
Why: Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01
- Lots / codes
Lot 66482CW, Exp 04/16
- Quantity
- 9,236 bottles
- Company
- Astellas Pharma US Inc, Northbrook, IL
- Distribution
- Nationwide
- Initiated
- September 15, 2014 · Voluntary: Firm initiated
- Classified
- October 7, 2014
- Reported
- October 15, 2014
- Ended
- May 19, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Erlotinib
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.